162 related articles for article (PubMed ID: 21448995)
21. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model.
Weissenstein C; Human P; Bezuidenhout D; Zilla P
J Heart Valve Dis; 2000 Mar; 9(2):230-40. PubMed ID: 10772041
[TBL] [Abstract][Full Text] [Related]
22. Transplantation material bovine pericardium: biomechanical and immunogenic characteristics after decellularization vs. glutaraldehyde-fixing.
Hülsmann J; Grün K; El Amouri S; Barth M; Hornung K; Holzfuß C; Lichtenberg A; Akhyari P
Xenotransplantation; 2012; 19(5):286-97. PubMed ID: 22978462
[TBL] [Abstract][Full Text] [Related]
23. Biomimetic acellular detoxified glutaraldehyde cross-linked bovine pericardium for tissue engineering.
Mathapati S; Bishi DK; Guhathakurta S; Cherian KM; Venugopal JR; Ramakrishna S; Verma RS
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1561-72. PubMed ID: 23827609
[TBL] [Abstract][Full Text] [Related]
24. Influence of polyethylene glycol graftings on the in vitro degradation and calcification of bovine pericardium.
Vasudev SC; Chandy T; Sharma CP
J Biomater Appl; 1997 Apr; 11(4):430-52. PubMed ID: 9178094
[TBL] [Abstract][Full Text] [Related]
25. Curcumin-crosslinked acellular bovine pericardium for the application of calcification inhibition heart valves.
Liu J; Li B; Jing H; Qin Y; Wu Y; Kong D; Leng X; Wang Z
Biomed Mater; 2020 May; 15(4):045002. PubMed ID: 31972553
[TBL] [Abstract][Full Text] [Related]
26. [Investigation of the degradation behavior of different modified bovine pericardial in vitro].
Wei Q; Wan C; Yao H; Li T; Xiong Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):214-8. PubMed ID: 12856582
[TBL] [Abstract][Full Text] [Related]
27. Response of macrophage-like U937 cells to decellularized tissue heart valve materials.
Ariganello MB; Labow RS; Lee JM
J Heart Valve Dis; 2009 Mar; 18(2):187-97. PubMed ID: 19455894
[TBL] [Abstract][Full Text] [Related]
28. Detoxified glutaraldehyde cross-linked pericardium: tissue preservation and mineralization mitigation in a subcutaneous rat model.
Valente M; Pettenazzo E; Thiene G; Molin GM; Martignago F; De Giorgi G; Gatti AM; Giaretta A; Pasquino E; Talenti E; Rinaldi S
J Heart Valve Dis; 1998 May; 7(3):283-91. PubMed ID: 9651841
[TBL] [Abstract][Full Text] [Related]
29. Polyethylene glycol (PEG) modified bovine pericardium as a biomaterial: a comparative study on immunogenicity.
Aravind S; Paul W; Vasudev SC; Sharma CP
J Biomater Appl; 1998 Oct; 13(2):158-65. PubMed ID: 9777465
[TBL] [Abstract][Full Text] [Related]
30. [Immunogenicity of acellular bovine pericardium in vivo].
Xiao Z; Zhang E; Li Y; Chen H; Lai Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Dec; 22(6):1203-5. PubMed ID: 16422100
[TBL] [Abstract][Full Text] [Related]
31. Calcification of decellularized and alpha-galactosidase-treated bovine pericardial tissue in an alpha-Gal knock-out mouse implantation model: comparison with primate pericardial tissue.
Kim MS; Lim HG; Kim YJ
Eur J Cardiothorac Surg; 2016 Mar; 49(3):894-900. PubMed ID: 25994817
[TBL] [Abstract][Full Text] [Related]
32. In vitro comparative assessment of decellularized bovine pericardial patches and commercial bioprosthetic heart valves.
Aguiari P; Iop L; Favaretto F; Fidalgo CM; Naso F; Milan G; Vindigni V; Spina M; Bassetto F; Bagno A; Vettor R; Gerosa G
Biomed Mater; 2017 Feb; 12(1):015021. PubMed ID: 28157718
[TBL] [Abstract][Full Text] [Related]
33. A novel anti-calcification strategy of bovine pericardium using sodium bisulfite modification.
Zhou J; Jiang H; Wang D; Hu S
J Heart Valve Dis; 2009 Mar; 18(2):180-5; discussion 186. PubMed ID: 19455893
[TBL] [Abstract][Full Text] [Related]
34. The effect of different treatment modalities on the calcification potential and cross-linking stability of bovine pericardium.
van den Heever JJ; Neethling WM; Smit FE; Litthauer D; Joubert G
Cell Tissue Bank; 2013 Mar; 14(1):53-63. PubMed ID: 22382933
[TBL] [Abstract][Full Text] [Related]
35. Improved calcification resistance and biocompatibility of tissue patch grafted with sulfonated PEO or heparin after glutaraldehyde fixation.
Lee WK; Park KD; Kim YH; Suh H; Park JC; Lee JE; Sun K; Baek MJ; Kim HM; Kim SH
J Biomed Mater Res; 2001; 58(1):27-35. PubMed ID: 11152994
[TBL] [Abstract][Full Text] [Related]
36. Amide cross-linking: an alternative to glutaraldehyde fixation.
Girardot JM; Girardot MN
J Heart Valve Dis; 1996 Sep; 5(5):518-25. PubMed ID: 8894992
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity of glutaraldehyde-tanned bovine pericardium.
Dahm M; Lyman WD; Schwell AB; Factor SM; Frater RW
J Thorac Cardiovasc Surg; 1990 Jun; 99(6):1082-90. PubMed ID: 2141662
[TBL] [Abstract][Full Text] [Related]
38. Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model.
Pettenazzo E; Valente M; Thiene G
Eur J Cardiothorac Surg; 2008 Aug; 34(2):418-22. PubMed ID: 18550382
[TBL] [Abstract][Full Text] [Related]
39. Prevention of tissue calcification on bioprosthetic heart valve by using epoxy compounds: a study of calcification tests in vitro and in vivo.
Xi T; Ma J; Tian W; Lei X; Long S; Xi B
J Biomed Mater Res; 1992 Sep; 26(9):1241-51. PubMed ID: 1429769
[TBL] [Abstract][Full Text] [Related]
40. Chemical modification of bovine pericardium and its effect on calcification in the rat subdermal model.
Bernacca GM; Dimitri WR; Fisher AC; Mackay TG; Wheatley DJ
Biomaterials; 1992; 13(6):345-52. PubMed ID: 1610957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
